{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:18:28Z","timestamp":1761581908165,"version":"3.37.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA127621"],"award-info":[{"award-number":["R01 CA127621"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adenovirus (AdV) infection is ubiquitous in the human population and causes acute infection in the respiratory and gastrointestinal tracts. In addition to lytic infections in epithelial cells, AdV can persist in a latent form in mucosal lymphocytes, and nearly 80% of children contain viral DNA in the lymphocytes of their tonsils and adenoids. Reactivation of latent AdV is thought to be the source of deadly viremia in pediatric transplant patients. Adenovirus latency and reactivation in lymphocytes is not well studied, though immune cell activation has been reported to promote productive infection from latency. Lymphocyte activation induces global changes in cellular gene expression along with robust changes in metabolic state. The ratio of free cytosolic NAD<jats:sup>+<\/jats:sup>\/NADH can impact gene expression via modulation of transcriptional repressor complexes. The NAD-dependent transcriptional co-repressor C-terminal Binding Protein (CtBP) was discovered 25\u2009years ago due to its high affinity binding to AdV E1A proteins, however, the role of this interaction in the viral life cycle remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The dynamics of persistently- and lytically-infected cells are evaluated. RT-qPCR is used to evaluate AdV gene expression following lymphocyte activation, treatment with nicotinamide, or disruption of CtBP-E1A binding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PMA and ionomycin stimulation shifts the NAD<jats:sup>+<\/jats:sup>\/NADH ratio in lymphocytic cell lines and upregulates viral gene expression. Direct modulation of NAD<jats:sup>+<\/jats:sup>\/NADH by nicotinamide treatment also upregulates early and late viral transcripts in persistently-infected cells. We found differential expression of the NAD-dependent CtBP protein homologs between lymphocytes and epithelial cells, and inhibition of CtBP complexes upregulates AdV E1A expression in T lymphocyte cell lines but not in lytically-infected epithelial cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data provide novel insight into factors that can regulate AdV infections in activated human lymphocytes and reveal that modulation of cellular NAD<jats:sup>+<\/jats:sup>\/NADH can de-repress adenovirus gene expression in persistently-infected lymphocytes. In contrast, disrupting the NAD-dependent CtBP repressor complex interaction with PxDLS-containing binding partners paradoxically alters AdV gene expression. Our findings also indicate that CtBP activities on viral gene expression may be distinct from those occurring upon metabolic alterations in cellular NAD<jats:sup>+<\/jats:sup>\/NADH ratios or those occurring after lymphocyte activation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12985-019-1265-y","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T12:02:29Z","timestamp":1576929749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes"],"prefix":"10.1186","volume":"16","author":[{"given":"Megan L.","family":"Dickherber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-3303","authenticated-orcid":false,"given":"Charlie","family":"Garnett-Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,21]]},"reference":[{"key":"1265_CR1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1542\/peds.76.3.420","volume":"76","author":"KM Edwards","year":"1985","unstructured":"Edwards KM, Thompson J, Paolini J, et al. Adenovirus infections in young children. [Internet]. Pediatrics. 1985;76:420\u20134 Available from: http:\/\/pediatrics.aappublications.org\/content\/76\/3\/420.","journal-title":"Pediatrics"},{"key":"1265_CR2","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1128\/JVI.02392-08","volume":"83","author":"CT Garnett","year":"2009","unstructured":"Garnett CT, Talekar G, Mahr JA, et al. Latent species C adenoviruses in human tonsil tissues. J Virol. 2009;83:2417\u201328.","journal-title":"J Virol"},{"key":"1265_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1128\/CMR.00116-13","volume":"27","author":"T Lion","year":"2014","unstructured":"Lion T. Adenovirus infections in Immunocompetent and Immunocompromised patients. Clin Microbiol Rev. 2014;27:441\u201362.","journal-title":"Clin Microbiol Rev"},{"key":"1265_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.7883\/yoken.JJID.2015.414","volume":"69","author":"AD Thounaojam","year":"2016","unstructured":"Thounaojam AD, Balakrishnan A, Mun AB. Detection and molecular typing of human adenoviruses associated with respiratory illnesses in Kerala. Jpn J Infect Dis. 2016;69:500\u20134.","journal-title":"Jpn J Infect Dis"},{"key":"1265_CR5","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1128\/JVI.76.21.10608-10616.2002","volume":"76","author":"CT Garnett","year":"2002","unstructured":"Garnett CT, Erdman D, Xu W, et al. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol. 2002;76:10608\u201316.","journal-title":"J Virol"},{"key":"1265_CR6","first-page":"256","volume":"67","author":"AS EVANS","year":"1958","unstructured":"EVANS AS. Latent adenovirus infections of the human respiratory tract. Am J Hyg. 1958;67:256\u201366.","journal-title":"Am J Hyg"},{"key":"1265_CR7","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1164\/ajrccm.164.supplement_2.2106063","volume":"164","author":"JC HOGG","year":"2001","unstructured":"HOGG JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med. 2001;164:S71\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"1265_CR8","doi-asserted-by":"publisher","first-page":"381.e1","DOI":"10.1016\/j.cmi.2015.12.013","volume":"22","author":"K Kosulin","year":"2016","unstructured":"Kosulin K, Geiger E, V\u00e9csei A, et al. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clinical Microbiology and Infection. 2016;22:381.e1\u20138.","journal-title":"Clinical Microbiology and Infection"},{"key":"1265_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ebiom.2017.12.030","volume":"28","author":"K Kosulin","year":"2018","unstructured":"Kosulin K, Berkowitsch B, Matthes S, et al. Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection post-transplant. EBioMedicine. 2018;28:114\u20139.","journal-title":"EBioMedicine"},{"key":"1265_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbmt.2013.11.009","volume":"20","author":"M Mynarek","year":"2014","unstructured":"Mynarek M, Ganzenmueller T, Mueller-Heine A, et al. Patient, virus, and treatment-related risk Factorsin pediatric adenovirus infection after stem cell transplantation: results of a routine monitoring program. Biol Blood Marrow Transplant. 2014;20:250\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1265_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/cid\/ciu225","volume":"59","author":"DF Wurzel","year":"2014","unstructured":"Wurzel DF, Mackay IM, Marchant JM, et al. Adenovirus species C is associated with chronic Suppurative lung diseases in children. Clin Infect Dis. 2014;59:34\u201340.","journal-title":"Clin Infect Dis"},{"key":"1265_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2141.2005.05649.x","volume":"130","author":"B Kampmann","year":"2005","unstructured":"Kampmann B, Cubitt D, Walls T, et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol. 2005;130:595\u2013603.","journal-title":"Br J Haematol"},{"key":"1265_CR13","unstructured":"DSouza A, Fretham C. Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides, 2018 [Internet]. CIBMTR. Available from: https:\/\/www.cibmtr.org, [cited 2019 30 Aug ]."},{"key":"1265_CR14","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.3390\/ph3103343","volume":"3","author":"MMY Waye","year":"2010","unstructured":"Waye MMY, Sing CW. Anti-viral drugs for human adenoviruses. Pharmaceuticals. 2010;3:3343\u201354.","journal-title":"Pharmaceuticals"},{"key":"1265_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/QCO.0000000000000379","volume":"30","author":"YJ Lee","year":"2017","unstructured":"Lee YJ, Prockop SE, Papanicolaou GA. Approach to adenovirus infections in the setting of hematopoietic cell transplantation. Curr Opin Infect Dis. 2017;30:377\u201387.","journal-title":"Curr Opin Infect Dis"},{"key":"1265_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a120913","volume":"89","author":"JP Fox","year":"1969","unstructured":"Fox JP, Brandt CD, Wassermann FE, et al. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol. 1969;89:25\u201350.","journal-title":"Am J Epidemiol"},{"key":"1265_CR17","doi-asserted-by":"publisher","first-page":"8799","DOI":"10.1128\/JVI.00562-10","volume":"84","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huang W, Ornelles DA, et al. Modeling adenovirus latency in human lymphocyte cell lines. J Virol. 2010;84:8799\u2013810.","journal-title":"J Virol"},{"key":"1265_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/jmv.23736","volume":"86","author":"D Markel","year":"2014","unstructured":"Markel D, Lam E, Harste G, et al. Type dependent patterns of human adenovirus persistence in human T-lymphocyte cell lines. J Med Virol. 2014;86:785\u201394.","journal-title":"J Med Virol"},{"key":"1265_CR19","doi-asserted-by":"publisher","first-page":"e00166","DOI":"10.1128\/JVI.00166-17","volume":"91","author":"T Krzywkowski","year":"2017","unstructured":"Krzywkowski T, Ciftci S, Assadian F, et al. Simultaneous single-cell In Situ analysis of human adenovirus type 5 DNA and mRNA expression patterns in lytic and persistent infection. J Virol. 2017;91:e00166\u201317.","journal-title":"J Virol"},{"key":"1265_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.virol.2013.08.024","volume":"447","author":"Y Furuse","year":"2013","unstructured":"Furuse Y, Ornelles DA, Cullen BR. Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA. Virology. 2013;447:140\u20135.","journal-title":"Virology"},{"key":"1265_CR21","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1128\/JVI.01675-13","volume":"88","author":"VK Murali","year":"2014","unstructured":"Murali VK, Ornelles DA, Gooding LR, et al. Adenovirus death protein (ADP) is required for lytic infection of human lymphocytes. J Virol. 2014;88:903\u201312.","journal-title":"J Virol"},{"key":"1265_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.it.2008.08.005","volume":"29","author":"L Racioppi","year":"2008","unstructured":"Racioppi L, Means AR. Calcium\/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller. Trends Immunol. 2008;29:600\u20137.","journal-title":"Trends Immunol"},{"key":"1265_CR23","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/nar\/gkr1076","volume":"40","author":"AN Giberson","year":"2012","unstructured":"Giberson AN, Davidson AR, Parks RJ. Chromatin structure of adenovirus DNA throughout infection. Nucleic Acids Res. 2012;40:2369\u201376.","journal-title":"Nucleic Acids Res"},{"key":"1265_CR24","doi-asserted-by":"publisher","first-page":"9645","DOI":"10.1074\/jbc.270.16.9645","volume":"270","author":"K Matsumoto","year":"1998","unstructured":"Matsumoto K, Okuwaki M, Kawase H, et al. Stimulation of DNA transcription by the replication factor from the adenovirus genome in a chromatin-like structure. J Biol Chem. 1998;270:9645\u201350.","journal-title":"J Biol Chem"},{"key":"1265_CR25","doi-asserted-by":"publisher","first-page":"34511","DOI":"10.1074\/jbc.273.51.34511","volume":"273","author":"M Okuwaki","year":"1998","unstructured":"Okuwaki M, Nagata K. Template activating factor-I remodels the chromatin structure and stimulates transcription from the chromatin template*. J Biol Chem. 1998;273:34511\u20138.","journal-title":"J Biol Chem"},{"key":"1265_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/j.1460-2075.1993.tb05679.x","volume":"12","author":"JM Boyd","year":"1993","unstructured":"Boyd JM, Subramanian T, Schaeper U, et al. A region in the C-terminus of adenovirus 2\/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 1993;12:469\u201378.","journal-title":"EMBO J"},{"key":"1265_CR27","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1073\/pnas.92.23.10467","volume":"92","author":"U Schaeper","year":"1995","unstructured":"Schaeper U, Boyd JM, Verma S, et al. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A. 1995;92:10467\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1265_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1515\/bmc-2014-0027","volume":"5","author":"TR Stankiewicz","year":"2014","unstructured":"Stankiewicz TR, Gray JJ, Winter AN, et al. C-terminal binding proteins: central players in development and disease. Biomolecular Concepts. 2014;5:489\u2013511.","journal-title":"Biomolecular Concepts"},{"key":"1265_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/MCB.19.1.777","volume":"19","author":"RGAB Sewalt","year":"1999","unstructured":"Sewalt RGAB, Gunster MJ, van der Vlag J, et al. C-terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Mol Cell Biol. 1999;19:777\u201387.","journal-title":"Mol Cell Biol"},{"key":"1265_CR30","doi-asserted-by":"publisher","first-page":"9101","DOI":"10.1074\/jbc.RA118.002514","volume":"293","author":"AG Bellesis","year":"2018","unstructured":"Bellesis AG, Jecrois AM, Hayes JA, et al. Assembly of human C-terminal binding protein (CtBP) into tetramers. J Biol Chem. 2018;293:9101\u201312.","journal-title":"J Biol Chem"},{"key":"1265_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nature01550","volume":"422","author":"Y Shi","year":"2003","unstructured":"Shi Y, Sawada J-I, Sui G, et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature. 2003;422:735\u20138.","journal-title":"Nature"},{"key":"1265_CR32","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1069300","volume":"295","author":"Q Zhang","year":"2002","unstructured":"Zhang Q, Piston DW, Goodman RH. Regulation of Corepressor function by nuclear NADH. Science. 2002;295:1895\u20137.","journal-title":"Science"},{"key":"1265_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1097-2765(02)00650-0","volume":"10","author":"V Kumar","year":"2002","unstructured":"Kumar V, Carlson JE, Ohgi KA, et al. Transcription Corepressor CtBP is an NAD+-regulated dehydrogenase. Mol Cell. 2002;10:857\u201369.","journal-title":"Mol Cell"},{"key":"1265_CR34","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1016\/j.febslet.2007.10.011","volume":"581","author":"P Mani-Telang","year":"2007","unstructured":"Mani-Telang P, Sutrias-Grau M, Williams G, et al. Role of NAD binding and catalytic residues in the C-terminal binding protein corepressor. FEBS Lett. 2007;581:5241\u20136.","journal-title":"FEBS Lett"},{"key":"1265_CR35","doi-asserted-by":"crossref","unstructured":"Shen Y, Kapfhamer D, Minnella AM, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun. 2017:1\u201313.","DOI":"10.1038\/s41467-017-00707-0"},{"key":"1265_CR36","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.12659\/MSM.912735","volume":"24","author":"Y Deng","year":"2018","unstructured":"Deng Y, Li H, Yin X, et al. C-terminal binding protein 1 modulates cellular redox via feedback regulation of MPC1 and MPC2 in melanoma cells. Med Sci Monit. 2018;24:7614\u201324.","journal-title":"Med Sci Monit"},{"key":"1265_CR37","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1128\/JVI.00104-08","volume":"82","author":"P Pelka","year":"2008","unstructured":"Pelka P, Ablack JNG, Fonseca GJ, et al. Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol. 2008;82:7252\u201363.","journal-title":"J Virol"},{"key":"1265_CR38","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1128\/JVI.00248-08","volume":"82","author":"RK Bruton","year":"2008","unstructured":"Bruton RK, Pelka P, Mapp KL, et al. Identification of a second CtBP binding site in adenovirus type 5 E1A conserved region 3. J Virol. 2008;82:8476\u201386.","journal-title":"J Virol"},{"key":"1265_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.virol.2013.05.018","volume":"443","author":"T Subramanian","year":"2013","unstructured":"Subramanian T, Zhao L-J, Chinnadurai G. Interaction of CtBP with adenovirus E1A suppresses immortalization of primary epithelial cells and enhances virus replication during productive infection. Virology. 2013;443:313\u201320.","journal-title":"Virology"},{"key":"1265_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chom.2017.11.008","volume":"22","author":"NR Zemke","year":"2017","unstructured":"Zemke NR, Berk AJ. The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling. Cell Host Microbe. 2017;22:789\u2013800.e5.","journal-title":"Cell Host Microbe"},{"key":"1265_CR41","first-page":"415","volume":"4","author":"T Subramanian","year":"1989","unstructured":"Subramanian T, La Regina M, Chinnadurai G. Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene. 1989;4:415\u201320.","journal-title":"Oncogene"},{"key":"1265_CR42","first-page":"1171","volume":"6","author":"T Subramanian","year":"1991","unstructured":"Subramanian T, Malstrom SE, Chinnadurai G. Requirement of the C-terminal region of adenovirus E1a for cell transformation in cooperation with E1b. Oncogene. 1991;6:1171\u20133.","journal-title":"Oncogene"},{"key":"1265_CR43","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1128\/JVI.00786-13","volume":"87","author":"MJ Cohen","year":"2013","unstructured":"Cohen MJ, Yousef AF, Massimi P, et al. Dissection of the C-terminal region of E1A redefines the roles of CtBP and other cellular targets in oncogenic transformation. J Virol. 2013;87:10348\u201355.","journal-title":"J Virol"},{"key":"1265_CR44","doi-asserted-by":"publisher","first-page":"36613","DOI":"10.1074\/jbc.M603550200","volume":"281","author":"L-J Zhao","year":"2006","unstructured":"Zhao L-J, Subramanian T, Chinnadurai G. Changes in C-terminal binding protein 2 (CtBP2) Corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2. J Biol Chem. 2006;281:36613\u201323.","journal-title":"J Biol Chem"},{"key":"1265_CR45","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1074\/jbc.M509051200","volume":"281","author":"L-J Zhao","year":"2006","unstructured":"Zhao L-J, Subramanian T, Zhou Y, et al. Acetylation by p300 regulates nuclear localization and function of the transcriptional Corepressor CtBP2. J Biol Chem. 2006;281:4183\u20139.","journal-title":"J Biol Chem"},{"key":"1265_CR46","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.1038\/sj.onc.1210569","volume":"26","author":"L-J Zhao","year":"2007","unstructured":"Zhao L-J, Subramanian T, Vijayalingam S, et al. PLDLS-dependent interaction of E1A with CtBP: regulation of CtBP nuclear localization and transcriptional functions. Oncogene. 2007;26:7544\u201351.","journal-title":"Oncogene"},{"key":"1265_CR47","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1073\/pnas.71.8.3283","volume":"71","author":"G Klein","year":"1974","unstructured":"Klein G, Lindahl T, Jondal M, et al. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci. 1974;71:3283\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"1265_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0168-1702(95)00071-2","volume":"39","author":"AJ Bett","year":"1995","unstructured":"Bett AJ, Krougliak V, Graham FL. DNA sequence of the deletion\/insertion in early region 3 of Ad5 dl309. Virus Res. 1995;39:75\u201382.","journal-title":"Virus Res"},{"key":"1265_CR49","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1128\/JVI.78.13.6955-6966.2004","volume":"78","author":"AL McNees","year":"2004","unstructured":"McNees AL, Mahr JA, Ornelles D, et al. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J Virol. 2004;78:6955\u201366.","journal-title":"J Virol"},{"key":"1265_CR50","doi-asserted-by":"crossref","unstructured":"Ornelles DA, Gooding LR, Dickherber ML, et al Limited but durable changes to cellular gene expression in a model of latent adenovirus infection are reflected in childhood leukemic cell lines. [Internet]. Virology 2016;494 IS -:67\u201377.Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0042682216300356","DOI":"10.1016\/j.virol.2016.03.015"},{"key":"1265_CR51","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"1265_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.ge.20.120186.000401","volume":"20","author":"A Berk","year":"1986","unstructured":"Berk A. Adenovirus promoters and E1A transactivation. Annu Rev Genet. 1986;20:45\u201379.","journal-title":"Annu Rev Genet"},{"key":"1265_CR53","unstructured":"Berk AJ. Adenoviridae. In: Knipe DM, Howley PM, editor(s). Fields Virology, 6th Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2013. p. 1704\u20131731."},{"key":"1265_CR54","doi-asserted-by":"publisher","first-page":"e0211192","DOI":"10.1371\/journal.pone.0211192","volume":"14","author":"L Crisostomo","year":"2019","unstructured":"Crisostomo L, Soriano AM, Mendez M, et al. Temporal dynamics of adenovirus 5 gene expression in normal human cells. PLoS One. 2019;14:e0211192\u201318.","journal-title":"PLoS One"},{"key":"1265_CR55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JVI.32.3.727-733.1979","volume":"32","author":"JR Nevins","year":"1979","unstructured":"Nevins JR, Ginsberg HS, Blanchard JM, et al. Regulation of the primary expression of the early adenovirus transcription units. J Virol. 1979;32:727\u201333.","journal-title":"J Virol"},{"key":"1265_CR56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/MR.46.4.377-383.1982","volume":"46","author":"JS Logan","year":"1982","unstructured":"Logan JS, Shenk T. Transcriptional and translational control of adenovirus gene expression. Microbiol Rev. 1982;46:377\u201383.","journal-title":"Microbiol Rev"},{"key":"1265_CR57","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","volume":"413","author":"M Shipkova","year":"2012","unstructured":"Shipkova M, Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta. 2012;413:1338\u201349.","journal-title":"Clin Chim Acta"},{"key":"1265_CR58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1290\/1071-2690(2001)037<0465:IOAROT>2.0.CO;2","volume":"37","author":"Q Gai","year":"2001","unstructured":"Gai Q, James CBL. Identification of a region on the adenovirus E1A gene responsible for induction by Phorbol Ester tumor promoter. In Vitro Cellular Developmental Biology. 2001;37:465\u201370.","journal-title":"In Vitro Cellular Developmental Biology"},{"key":"1265_CR59","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1002\/j.1460-2075.1989.tb08609.x","volume":"8","author":"L Buckbinder","year":"1989","unstructured":"Buckbinder L, Miralles VJ, Reinberg D. TPA can overcome the requirement for EIa and together act synergistically in stimulating expression of the adenovirus EIII promoter. EMBO J. 1989;8:4239\u201350.","journal-title":"EMBO J"},{"key":"1265_CR60","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.4049\/jimmunol.1301395","volume":"191","author":"CD Scharer","year":"2013","unstructured":"Scharer CD, Barwick BG, Youngblood BA, et al. Global DNA methylation remodeling accompanies CD8 T cell effector function. J Immunol. 2013;191:3419\u201329.","journal-title":"J Immunol"},{"key":"1265_CR61","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.4049\/jimmunol.1602086","volume":"198","author":"CD Scharer","year":"2017","unstructured":"Scharer CD, Bally APR, Gandham B, et al. Cutting edge: chromatin accessibility programs CD8 T cell memory. J Immunol. 2017;198:2238\u201343.","journal-title":"J Immunol"},{"key":"1265_CR62","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood-2011-10-292003","volume":"119","author":"T Akimova","year":"2012","unstructured":"Akimova T, Beier UH, Liu Y, et al. Histone\/protein deacetylases and T-cell immune responses. Blood. 2012;119:2443\u201351.","journal-title":"Blood"},{"key":"1265_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0014-4827(82)90010-6","volume":"137","author":"NA Berger","year":"1982","unstructured":"Berger NA, Berger SJ, Sikorski GW, et al. Amplification of pyridine nucleotide pools in mitogen-stimulated human lymphocytes. Exp Cell Res. 1982;137:79\u201388.","journal-title":"Exp Cell Res"},{"key":"1265_CR64","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1101\/gad.289140.116","volume":"30","author":"JA van der Knaap","year":"2016","unstructured":"van der Knaap JA, Verrijzer CP. Undercover: gene control by metabolites and metabolic enzymes. Genes Dev. 2016;30:2345\u201369.","journal-title":"Genes Dev"},{"key":"1265_CR65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/v11020141","volume":"11","author":"MA Prusinkiewicz","year":"2019","unstructured":"Prusinkiewicz MA, Mymryk JS. Metabolic reprogramming of the host cell by human adenovirus infection. Viruses. 2019;11:141\u201321.","journal-title":"Viruses"},{"key":"1265_CR66","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI64264","volume":"123","author":"AF Santidrian","year":"2013","unstructured":"Santidrian AF, Matsuno-Yagi A, Ritland M, et al. Mitochondrial complex I activity and NAD+\/NADH balance regulate breast cancer progression. J Clin Invest. 2013;123:1068\u201381.","journal-title":"J Clin Invest"},{"key":"1265_CR67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.genet.31.1.177","volume":"31","author":"J Flint","year":"1997","unstructured":"Flint J, Shenk T. VIRAL TRANSACTIVATING PROTEINS. Annu Rev Genet. 1997;31:177\u2013212.","journal-title":"Annu Rev Genet"},{"key":"1265_CR68","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/JVI.65.6.3083-3094.1991","volume":"65","author":"LR Gooding","year":"1991","unstructured":"Gooding LR, Aquino L, Duerksen-Hughes PJ, et al. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol. 1991;65:3083\u201394.","journal-title":"J Virol"},{"key":"1265_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.virol.2015.10.019","volume":"487","author":"JG Gomez-Gutierrez","year":"2016","unstructured":"Gomez-Gutierrez JG, Nitz J, Sharma R, et al. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Virology. 2016;487:249\u201359.","journal-title":"Virology"},{"key":"1265_CR70","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/1087057114561400","volume":"20","author":"MA Blevins","year":"2015","unstructured":"Blevins MA, Kouznetsova J, Krueger AB, et al. Small molecule, NSC95397, inhibits the CtBP1-protein partner interaction and CtBP1-mediated transcriptional repression. J Biomol Screen. 2015;20:663\u201372.","journal-title":"J Biomol Screen"},{"key":"1265_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/infdis\/jiw499","volume":"215","author":"E Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez E, Ip WH, Kolbe V, et al. Humanized mice reproduce acute and persistent human adenovirus infection. J Infect Dis. 2017;215:70\u20139.","journal-title":"J Infect Dis"},{"key":"1265_CR72","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1016\/S0021-9258(18)31720-4","volume":"269","author":"EF Greiner","year":"1994","unstructured":"Greiner EF, Guppy M, Brand K. Essential for proliferation and the glycolytic enzyme induction that ProvokeasTransition to glycolytic energy production. J Biol Chem. 1994;269:31484\u201390.","journal-title":"J Biol Chem"},{"key":"1265_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol. 2013;31:259\u201383.","journal-title":"Annu Rev Immunol"},{"key":"1265_CR74","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","volume":"74","author":"ES Hwang","year":"2017","unstructured":"Hwang ES, Song SB. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci. 2017;74:3347\u201362.","journal-title":"Cell Mol Life Sci"},{"key":"1265_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/cmi.2017.115","volume":"15","author":"X Zhang","year":"2018","unstructured":"Zhang X, Liu J, Cao X. Metabolic control of T-cell immunity via epigenetic mechanisms. Cell Mol Immunol. 2018;15:203\u20135.","journal-title":"Cell Mol Immunol"},{"key":"1265_CR76","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.smim.2016.10.009","volume":"28","author":"L Almeida","year":"2016","unstructured":"Almeida L, Lochner M, Berod L, et al. Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. 2016;28:514\u201324.","journal-title":"Semin Immunol"},{"issue":"2","key":"1265_CR77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1097-2765(02)00443-4","volume":"9","author":"G Chinnadurai","year":"2002","unstructured":"Chinnadurai G. CtBP, an Unconventional Transcriptional Corepressor in Development and Oncogenesis. Molecular Cell. 9:213\u201324.","journal-title":"Molecular Cell"},{"key":"1265_CR78","doi-asserted-by":"publisher","first-page":"27836","DOI":"10.1074\/jbc.M113.493569","volume":"288","author":"DL Madison","year":"2013","unstructured":"Madison DL, Wirz JA, Siess D, et al. Nicotinamide adenine dinucleotide-induced Multimerization of the co-repressor CtBP1 relies on a switching tryptophan. J Biol Chem. 2013;288:27836\u201348.","journal-title":"J Biol Chem"},{"key":"1265_CR79","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0014-5793(03)00275-8","volume":"540","author":"T Subramanian","year":"2003","unstructured":"Subramanian T, Chinnadurai G. Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett. 2003;540:255\u20138.","journal-title":"FEBS Lett"},{"key":"1265_CR80","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/nar\/24.13.2578","volume":"24","author":"K Sollerbrandt","year":"1996","unstructured":"Sollerbrandt K, Chinnadurai G, Svensson C. The CtBP binding domain in the adenovirus E1Aprotein controls CR1-dependent transactivation. Nucleic Acids Res. 1996;24:2578\u201384.","journal-title":"Nucleic Acids Res"},{"key":"1265_CR81","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/sj.gt.3300394","volume":"4","author":"O Ebert","year":"1997","unstructured":"Ebert O, Finke S, Salahi A, et al. Lymphocyte apoptosis: induction by gene transfer techniques. Gene Ther. 1997;4:296\u2013302.","journal-title":"Gene Ther"},{"key":"1265_CR82","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ymthe.2005.07.688","volume":"13","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Zheng Z, Cohen CJ, et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther. 2005;13:151\u20139.","journal-title":"Mol Ther"},{"key":"1265_CR83","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1097-2765(03)00175-8","volume":"11","author":"X Lin","year":"2003","unstructured":"Lin X, Sun B, Liang M, et al. Opposed regulation of Corepressor CtBP by SUMOylation and PDZ binding. Mol Cell. 2003;11:1389\u201396.","journal-title":"Mol Cell"},{"issue":"1","key":"1265_CR84","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2121-7-35","volume":"7","author":"Lee M Bergman","year":"2006","unstructured":"Bergman LM, Morris L, Darley M, et al. Role of the unique N-terminal domain of CtBP2 in determining the subcellular localisation of CtBP family proteins. BMC Cell Biol. 2006;7.","journal-title":"BMC Cell Biology"},{"key":"1265_CR85","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/emboj\/18.12.3392","volume":"18","author":"P Criqui-Filipe","year":"1999","unstructured":"Criqui-Filipe P, Ducret C, Maira S-M, et al. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J. 1999;18:3392\u2013403.","journal-title":"EMBO J"},{"key":"1265_CR86","doi-asserted-by":"publisher","first-page":"10223","DOI":"10.1128\/MCB.24.23.10223-10235.2004","volume":"24","author":"R Alpatov","year":"2004","unstructured":"Alpatov R, Munguba GC, Caton P, et al. Nuclear speckle-associated protein Pnn\/DRS binds to the transcriptional corepressor CtBP and relieves CtBP-mediated repression of the E-cadherin gene. Mol Cell Biol. 2004;24:10223\u201335.","journal-title":"Mol Cell Biol"},{"key":"1265_CR87","doi-asserted-by":"publisher","first-page":"e1005415","DOI":"10.1371\/journal.ppat.1005415","volume":"12","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Stamminger T, Hearing P. E2F\/Rb family proteins mediate interferon induced repression of adenovirus immediate early transcription to promote persistent viral infection. PLoS Pathog. 2016;12:e1005415\u201324.","journal-title":"PLoS Pathog"},{"key":"1265_CR88","doi-asserted-by":"crossref","unstructured":"Koyuncu E, Budayeva HG, Miteva YV, et al. Sirtuins Are Evolutionarily Conserved Viral Restriction Factors mBio. 2014;5:e02249\u201314.","DOI":"10.1128\/mBio.02249-14"},{"key":"1265_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/09637480903430990","volume":"61","author":"AA Matias","year":"2010","unstructured":"Matias AA, Serra AT, Silva AC, et al. Portuguese winemaking residues as a potential source of natural anti-adenoviral agents. Int J Food Sci Nutr. 2010;61:357\u201368.","journal-title":"Int J Food Sci Nutr"},{"key":"1265_CR90","first-page":"184","volume":"17","author":"KE Picchione","year":"2010","unstructured":"Picchione KE, Bhattacharjee A. Viral genome silencing by neuronal sirtuin 1. J Neuro-Oncol. 2010;17:184\u20138.","journal-title":"J Neuro-Oncol"},{"key":"1265_CR91","first-page":"738","volume":"93","author":"K Nebenzahl-Sharon","year":"2019","unstructured":"Nebenzahl-Sharon K, Sharf R, Amer J, et al. An interaction with PARP-1 and inhibition of Parylation contribute to attenuation of DNA damage signaling by the adenovirus E4orf4 protein. J Virol. 2019;93:738\u201320.","journal-title":"J Virol"},{"key":"1265_CR92","doi-asserted-by":"crossref","unstructured":"Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly (ADP-ribose) and PARPs. 2012:1\u201314.","DOI":"10.1038\/nrm3376"},{"key":"1265_CR93","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ceb.2008.03.006","volume":"20","author":"WL Kraus","year":"2008","unstructured":"Kraus WL. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol. 2008;20:294\u2013302.","journal-title":"Curr Opin Cell Biol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-019-1265-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-019-1265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T05:41:04Z","timestamp":1665294064000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-019-1265-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1186\/s12985-019-1265-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}